Highlights in management of early stage non-small cell lung cancer
In October 2013, our sister Journal Translational Lung Cancer Research is going to launch a special issue on Management of Early Stage Non-Small Cell Lung Cancer. This special issue is guest-edited by Dr. Heather Wakelee, from Stanford Cancer Institute, Stanford University, USA. The scope of the special issue will be to provide cutting-edge literature on related fields and a platform for key experts to present their latest research results.
Apart from updates in surgical techniques, this special issue on Management of Early Stage Non-Small Cell Lung Cancer will present reviews on the importance of adequate lymph node sampling and on known prognostic biomarkers. We also have input on management for non-surgical patients, IR techniques, interventional pulmonology strategies and input from radiation oncologists. More interesting and exciting contents are coming up. Hope you will enjoy it.
Preview of the special issue:
- Interventional Pulmonology Approaches in diagnosis and treatment of early stage NSCLC
Author: Arthur Sung
Division of Pulmonary and Critical Care Medicine, New York Methodist Hospital, New York, USA - Management of Ground Glass Opacities
Author: Tetsuya Mitsudomi
Aichi Cancer Center Hospital, Nagoya, Japan - Potential Role of limited resections for small peripheral early stage NSCLC
Author: Masahiro Tsuboi
Department of Thoracic Surgery and Oncology, Tokyo Medical University and Hospital, Tokyo, Japan - Towards Optimal Pathologic Staging of Resectable Non-Small Cell Lung Cancer
Author: Raymond Osarogiagbon, Gail Darling
Division of Oncology, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA - Alternatives to Surgery in Early Stage Disease—SABR
Author: Andrea Bezjak
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada - Prognostic and Predictive Biomarkers in early stage NSCLC—tumor based approaches including gene signatures
Author: Giorgio Scagliotti
Department of Oncology, University of Turin, San Luigi Hospital, Regione Gonzale, Orbassano, Turin, Italy - Prognostic and Predictive Biomarkers in early stage NSCLC—CTCs and serum/plasma markers
Author: Fiona Blackhall
Department of Medical Oncology, Christie Hospital, Manchester, UK - Neoadjuvant chemotherapy in early-stage non-small cell lung cancer
Author: Enriqueta Felip-Font
Oncology Service, Hospital Universitario de la Vall, Bacerlona - Adjuvant Chemotherapy of Completely Resected Early Stage Non-Small Cell Lung Cancer (NSCLC)
Author: Heather Wakelee, Ying Liang
Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University, Stanford, CA, USA - Adjuvant Molecularly Targeted Therapy—Epidermal Growth Factor Tyrosine Kinase Inhibition and Beyond
Author: Lecia Sequist, Joel Neal
Massachusetts General Hospital Cancer Center, Boston, USA - Adjuvant Immune-Based Therapy
Author: Charles Butts
Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada - Post-Operative Radiation Therapy
Author: Cécile Le Péchoux
Institut Gustave Roussy, Radiotherapy Department, France - Alternative to Surgery in Early Stage NSCLC—Interventional Radiologic Approaches
Author: Bradley Pua
New York-Presbyterian/Weill Cornell
Acknowledgements
Disclosure: The author declares no conflict of interest.